NRC
CL icon

New Republic Capital’s Colgate-Palmolive CL Stock Holding History

New Republic Capital’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$377K Buy
+4,425
New +$394K 0.13% 151

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

New Republic Capital's CL Position: Q1 2026 in Review

New Republic Capital opened a new position in Colgate-Palmolive (CL) in Q1 2026: 4,425 shares worth $377K. The stake represents 0.13% of the portfolio and ranks #151 among its holdings.

1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • New Republic Capital held 4,425 shares of Colgate-Palmolive worth $377K as of Q1 2026.
  • Colgate-Palmolive was a new New Republic Capital position in Q1 2026.
  • Colgate-Palmolive made up 0.13% of New Republic Capital's portfolio in Q1 2026, its #151 holding.
  • 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on New Republic Capital's 13F filing for Q1 2026, filed 1 May 2026.